AI-Powered Diligence Human Intelligence

The short list
starts here.

A boutique intelligence firm pairing AI-driven diligence with operator judgment. We review every venture ourselves — and forward only the few that earn a place in front of serious capital.

5-minute mini pitch Every one read by our team One submission per company
[ What we do ]

Signal. Not noise.

Early-stage deal flow is loud. Ours isn't. We do the commercial, scientific, and strategic work before a founder ever reaches an investor's inbox.

01

Curated deal flow

A private, diligence-ready stream of early-stage opportunities — reserved for a small circle of venture funds, family offices, and strategic investors.

02

AI + human vetting

Every submission is transcribed and analyzed by our models, then judged by people who have built companies, raised capital, and taught innovation at the graduate level.

03

The short list

No public deal board. No wide syndication. The ventures we forward to our clients are the ones we would back ourselves.

[ How it works ]

A process built by operators.

No black box. Here is what happens between a mini pitch arriving and a founder hearing back.

  1. 1

    Submit

    A mini pitch — a 1–2 page summary and a 5-minute video. No endless forms, no fees, no gatekeepers-for-hire. Just your sharpest case for the opportunity.

  2. 2

    Review

    AI surfaces the signal; our team weighs the problem, solution, team, traction, and ask — drawing on decades across biotech, venture capital, AI, and applied research.

  3. 3

    Package

    What clears our bar becomes an investor-ready intelligence brief, matched to the clients whose thesis it fits.

  4. 4

    Introduce

    Founders who make the cut receive warm, qualified introductions to capital that is already primed — never cold outreach into a void.

[ Our team ]

Operators. Scientists. Investors.

Our partners have collectively spent more than five decades on both sides of the venture table — building, funding, researching, and teaching the next generation.

Daniel Sem, PhD

Venture & Investor Relations

President, Walsh Ventures · Executive Director, Center for Innovation and Entrepreneurship at Walsh College · President, CU Ventures · Managing Partner, Talents Fund · CEO, Bridge to Cures. 25+ years in biotech innovation, IP strategy, and venture formation. PhD Biochemistry, University of Wisconsin–Madison. MBA, Marquette. Admitted to the Wisconsin Bar.

Dr. Michael Litman, PhD

Technology & Intelligence Systems

Founder, AI & Quantum Innovation Lab at Concordia University Wisconsin · Professor and Chair of Computer Science · Quantum Computing Advisory Board Chair, OSR Applied Research · MIT Post-Graduate, Machine Learning Software Development. Nearly two decades of graduate-level teaching and applied research; software author since 2005.

Nick O'Brien

Strategy & Partnerships

Director, Impact Partners · Co-Founder, Families > Funds > Founders (F3). Deep experience across strategic partnerships, market research, lead generation, and public relations inside the family-office and impact-investing ecosystem.

Logan Montgomery

Co-founder

Computer Science scholar at Concordia University Wisconsin. Division III athlete — goalkeeper, CUW Men's Soccer. Brings the engineering discipline, application-layer craftsmanship, and fresh perspective that modern intelligence work demands.

[ Mini Pitch ]

It's not a form.
It's an audition.

A mini pitch is all it takes — a 1–2 page executive summary and a 5-minute video. Every one is read by our team. Only a fraction advance. If your venture stands up to operators who have spent decades building, funding, and teaching around innovation, we want to see it.

Submit Mini Pitch
No fees · No subscriptions · One submission per company